重型肝炎合并肺部感染临床分析

目的探讨重型肝炎合并肺部感染发生原因、危险因素、临床表现、预后。方法回顾性分析本院同一科室近1年米重型肝炎合并肺部感染的资料。结果48例重型肝炎有14例合并肺部感染。14例重型肝炎并肺部感染患者中均使用过抗生素，4例肺部感染前有侵袭性操作。肺部感染患者临床以发热、咳嗽及咳痰、肺部哕音、外周血白细胞升高、胸片改变为主。中晚期重型肝炎合并肺部感染发生率达78．5％，且治疗效果差，合并肺部感染病死率达71．43％。结论重型肝炎合并肺部感染发生率高，临床表现多样，病死率高，临床医务人员必须高度重视，采取综合措施防治肺部感染，降低相关死亡率。

Severe hepatitis with pulmonary infection

Objective To explore the etiologies, risk factors, clinical manifestations, and prognosis of pulmonary infection in patients with severe hepatitis. Methods The data on severe hepatitis with pulmonary infection in our hospital were retrospectively analyzed. Results 14 of 48 patients developed pulmonary infection; all of those had a history of antibiotic use and 4 had invasive procedures. The main clinical features were fever, cough and sputum, pulmonary rales, leukocytosis in the peripheral blood, and abnormalities on chest X-ray. The incidence of pulmonary infection in the late stage of severe hepatitis was up to 78.5%, and the efficacy was bad, with a mortality rate of 71.43%. Conclusions The incidence of pulmonary infection in patients with severe hepatitis is high, with various clinical manifestations and a greater mortality rate. Clinicians should be very careful with severe hepatitis with pulmonary infection. Comprehensive measures should be taken to prevent and treat pulmonary infection to reduce the related mortality rate.